{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT00745693: Not Applicable Interventional Completed Coronary Disease
(2008)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01472016: Phase 1 Interventional Completed Advanced Solid Tumors
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Class:
PROTEIN
Status:
Investigational
Source:
NCT03031691: Phase 1 Interventional Completed Metastatic Colorectal Cancer
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
USAN:ENFORTUMAB [USAN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tendamistat [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01630798: Phase 1 Interventional Completed Barrett's Esophagus
(2012)
Source URL:
Class:
PROTEIN
Class:
PROTEIN
Norleusactide (Pentacosactride) is a synthetic polypeptide with a corticotropin-like action.
